Vitamin D Receptor Antagonists for Treating Breast Cancer
This invention relates to derivatives of calcitriol that can block cell growth without harmfully raising calcium levels. Specifically, these compounds act as antagonists of VDR blocking its ability to stimulate cell proliferation. This technology can be useful in treating breast cancer or other malignancies.
- Potential drugs for treating breast cancer and possibly also prostate cancer, colorectal cancer, leukemia, melanoma, or glioma
- Prevention of cancer in high-risk population
- Research on vitamin D receptor functions and cancer